Physician profile
Bruce Benedick
NPI 1346274602
$4,172.31
in general payments reported to CMS, 2019-2025
23 companies · $551 in 2025
The $551 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,612 · 2020: $731 · 2021: $11.72 · 2023: $241 · 2024: $25.00 · 2025: $551.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $817.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $817.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $617.98 | 2019-2021 | |
| E.R. Squibb & Sons, L.L.C. | $374.62 | 2019-2025 | Eliquis, Camzyos |
| Boehringer Ingelheim Pharmaceuticals, INC. | $347.08 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $333.26 | 2019-2020 | |
| Pfizer INC. | $315.36 | 2019-2020 | |
| Sanofi-Aventis U.S. LLC | $285.86 | 2019-2020 | |
| Atricure, INC. | $269.16 | 2025 | Epi-Sense Guided Coagulation System With Visitrax |
| Ablacon, INC. | $241.24 | 2023 | |
| Medicure Pharma INC. | $227.81 | 2020 | |
| Astrazeneca Pharmaceuticals LP | $220.76 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $166.90 | 2019-2020 | |
| Medtronic, INC. | $163.61 | 2025 | Aurora Ev-Icd Mri Surescan |
| Regeneron Healthcare Solutions, INC. | $160.72 | 2019 | |
| W. L. Gore & Associates, INC. | $98.32 | 2025 | Excluder Conformable Aaa Endoprosthesis With Active Control |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $74.09 | 2019 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $53.25 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $40.35 | 2019-2020 | |
| Daiichi Sankyo INC. | $40.16 | 2019 | |
| Novo Nordisk INC | $37.55 | 2019-2020 | |
| Abbott Laboratories | $33.99 | 2020 | |
| Amarin Pharma, INC. | $29.29 | 2019 | |
| Abiomed | $24.49 | 2020 | |
| Medtronic Vascular, INC. | $16.46 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bruce Benedick listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.